Other
Per Torp Sangild
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
80.0%-7% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
Failure Rate
20.0%
1 terminated/withdrawn out of 5 trials
Success Rate
80.0%
-6.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
N/A
4(100.0%)
4Total
N/A(4)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (5)
Showing 5 of 5 trials
NCT03085277Not ApplicableCompleted
Bovine Colostrum for Preterm Newborns
Role: lead
NCT03320785Terminated
Circulating Markers in Preterm Infants With Perinatal and Neonatal Inflammation
Role: lead
NCT03537365Not ApplicableCompleted
Bovine Colostrum as a Fortifier Added to Human Milk for Preterm Infants
Role: lead
NCT03822104Not ApplicableCompleted
Bovine Colostrum as a Human Milk Fortifier for Preterm Infants
Role: lead
NCT02054091Not ApplicableCompleted
Feeding Bovine Colostrum to Preterm Infants
Role: lead
All 5 trials loaded